Medtech Insight
>>Device Area

Liquid Biopsy Revolutionizing Cancer Care, But Costs Continue To Inhibit Global Potential

For much of the world, the full promise of liquid biopsy exceeds purchasing power.

29 Sep 2022

Liquid biopsy represents potential advantages over traditional approaches to cancer surveillance, treatment selection and recurrence monitoring. But one size does not fit all, requiring tailored solutions for less developed markets.

blood cells — Blood contains a number of substances useful in guiding treatment of cancer • Source: Shutterstock

Liquid biopsy could transform cancer care, but costs continue to be a major obstacle to liquid biopsy adoption and use, particularly in developing geographies.

From discovery to treatment and to recurrence monitoring, liquid biopsy testing empowers doctors to determine what cancer is present, where...